MEM
MEMPHASYS FPO [MEM]
Healthcare · ASX Small Cap
$0.0050 +11.1%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical55
Catalyst55
Sentiment50
Fundamental11
Momentum61
Risk Gate27
Get alerts when MEM's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Volume surging at 3.1x normal while price falls — heavy selling pressure
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Trading above the 200-day average — the long-term trend is on your side
- Critical cash runway (0.6 quarters)
- Very high P/S ratio (66.5x)
- Revenue in sharp decline (-96%)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- Positive long-term momentum — up 20% over the past year
- The bigger volume days are the up days — volume-weighted momentum is positive (0.57%/day)
- Altman Z-Score distress zone (1.33 < 1.81, low-confidence approx)
- Penny stock risk ($0.005)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Piotroski F-Score weak (2/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -96% — the top line is shrinking
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about MEM
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE MENA Orders Secured, Expanded & Operations Unaffected
NONE Appendix 4D - Half-year Financial Report - 31 December 2025
NONE Change in substantial holding
Announcement tone +5pts
Recent ASX Announcements
| 2026-03-19 | MENA Orders Secured, Expanded & Operations Unaffected PRICE SENSITIVE |
| 2026-02-26 | Appendix 4D - Half-year Financial Report - 31 December 2025 PRICE SENSITIVE |
| 2026-02-23 | Change in substantial holding |
| 2026-02-20 | Notification of cessation of securities - MEM |
| 2026-02-16 | Section 708A Cleansing Statement |
Key Metrics
$14.2M
Market Cap
1.9M
Avg Volume
3.1x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-87.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 60% |
| L | Leader vs Laggard | laggard | RS: -6 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #85 of 117 · Sector avg: 46
View all Healthcare signals →Track MEM and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required